Background This paper describes the ethnic and socioeconomic correlates of functioning in a cohort of long-term nonrecurring breast cancer survivors. Methods Participants (n = 804) in this study were women from the Health, Eating, Activity, and Lifestyle (HEAL) Study, a population-based, multicenter, multiethnic, prospective study of women newly diagnosed with in situ or Stages I to IIIA breast cancer. Measurements occurred at three timepoints following diagnosis. Outcomes included standardized measures of functioning . Results Overall, these long-term survivors reported values on two physical function subscales of the SF-36 slightly lower than population norms. Black women reported statistically significantly lower physical functioning (PF) scores (P = 0.01), compared with White and Hispanic women, but higher mental health (MH) scores (P < 0.01) compared with White and Hispanic women. In the final adjusted model, race was significantly related to PF, with Black participants and participants in the ''Other'' ethnic category reporting poorer functioning compared to the White referent group (P < 0.01, 0.05). Not working outside the home, being retired or disabled and being unemployed (on leave, looking for work) were associated with poorer PF compared to currently working (both P < 0.01). 85-95 DOI 10.1007/s10549-006-9479-2 Conclusion These data indicate that race/ethnicity influences psychosocial functioning in breast cancer survivors and can be used to identify need for targeted interventions to improve functioning.
Introduction
Recovery from breast cancer diagnosis and treatment is a multifaceted process. Several decrements in women's functioning have been documented in the short term, including reduction in overall quality of life and in more specific aspects of quality of life, such as increases in physiological and psychosocial symptoms including fatigue, mood disturbance, and a range of social and occupational changes [1] . Recent key papers [1] [2] [3] [4] indicate that many of the QOL difficulties experienced by survivors in the short term (i.e., during the first two years post diagnosis) resolve over time. However, there MIGHT BE a subgroup of approximately 20-25% of women who still report decrements in several aspects of QOL up to four years after diagnosis [1, 5, 6] .
Why does a subgroup report lower QOL after the first year of treatment? Several disparity-based explanations are explored in this paper. First, it is likely that demographic differences exist in long term functioning of cancer patients, although very little has been published on the survivorship experience of a demographically diverse group of women. The quality and experiences of survival could be quite different in women who differ by race or ethnicity [3] , or by socioeconomic status [1] , given the importance of these variables in determining survivorship. Other areas of research comparing women from varied ethnic and socioeconomic groups, including such outcomes as chronic disease, screening, health behavior, and general functioning, have found differences by sociodemographic variables [7, 8] , but little is known about the experience of survivorship across ethnic or sociodemographic groups.
Second, it is likely that continued presence of symptoms related to cancer and cancer treatment reduces overall QOL. Continuing experience of symptoms, including hormone related symptoms [5] , lymphedema [1, 9] , and fatigue [10] , could interfere with functioning. True differences in disease profile and even perceived prognosis might play a role too. Finally, the worry and fear of cancer recurrence would be another type of reminder of the initial experience, of vulnerability, and of potential mortality. There is qualitative evidence that better functioning over time is reported by women who are able to view and label themselves as survivors, and who consider their cancer diagnosis as a past experience rather than continuing to view themselves as cancer patients [11] . Worry about recurrence and its meaning could interfere with women's ability to put the cancer experience behind them and could interfere with their overall functioning. These potential psychosocial explanations (worry, symptoms) may also be related to the differences among demographic subgroups, providing clues to explain any disparities found.
The research aims of this paper are: (1) to describe the ethnic and socioeconomic correlates of functioning of a diverse cohort of long-term nonrecurring breast cancer survivors and (2) to determine the contribution of ongoing difficulties, including symptoms and concerns about cancer, to the ethnic and socioeconomic differences in functioning levels.
Methods

Study design
Participants were enrolled in the Health, Eating, Activity, and Lifestyle (HEAL) Study, a populationbased, multicenter, multiethnic, prospective study of women newly diagnosed with in situ or Stages I to IIIA breast cancer. HEAL study participants are being followed to determine the impact of weight, physical activity, diet, hormones, and other exposures on breast cancer prognosis. All study protocols were approved by the Institutional Review Boards of each participating center. The baseline interview occurred on average 6.1 months following diagnosis, followed by a 24 month and a 35 month post baseline assessment. Women with new primary cancer or recurrent cancer were excluded from all analyses.
Eligibility and recruitment
Female patients diagnosed with their first primary breast cancer were recruited from National Cancer Institute sponsored Surveillance Epidemiology and End Results (SEER) registries in three geographic regions of the United States, and data on two of the sites have been previously published [12] . Incident breast cancer patients at the third site (Los Angeles County, California) were initially recruited to participate in one of two population-based case-control studies, a study of in situ breast cancer [13, 14] and a study of invasive breast cancer [15, 16] . Women were eligible to participate in these two case control studies if they were age 35 to 64 years at diagnosis, Caucasian or Black, and born in the United States. Los Angeles County participants in these studies were included in the HEAL study if they were (1) Black, (2) diagnosed between May 1995 and May 1998, and (3) satisfied the HEAL stage eligibility criterion. Overall, less than 2.4% of the participants were beyond the 12-month window.
Measures
General functioning
We used the Medical Outcomes Study short form 36 (SF-36) health status measure created to measure physical and mental health functioning in healthy populations [17, 18] . This widely used measure includes 36 items, scored into eight subscales: Physical Functioning (PF), Role-Physical (RP), Bodily Pain (BP), General Health (GH), Vitality (VT), Social Functioning (SF), Role-Emotional (RE), and Mental Health (MH), and a physical component and a mental component summary scale, with high alpha coefficients (0.78-0.91).
Menopausal status
Menopausal status was determined at the 24-month assessment using an algorithm that assigned women into pre, post, or unclassifiable menopausal status based on the following data: age, date of last menstruation, hysterectomy and oophorectomy status.
Stage of breast cancer and treatment
Stage of disease was based on SEER data. Treatment data were recoded as: surgery only; surgery with chemotherapy; surgery with radiation, or the combination of all three treatments. Tamoxifen use was categorized as use between baseline and 24-months, use at or before baseline only, or no use during the study period.
Antidepressant use
Self-reported use of antidepressant medication was collected at the 24-month assessment and categorized as currently taking at 24 months versus not currently taking at 24 months.
Hormone-related symptom checklist
Hormone symptoms were measured with 14 items representing the most relevant symptoms for a population of breast cancer survivors [19] .
Lymphedema
We constructed an index of self-reported lymphedema, with three levels: currently experiencing lymphedema (current lymphedema, 13.9%), did experience lymphedema, but not currently experiencing lymphedema (no current lymphedema, 6.1%), and never experienced lymphedema (never had lymphedema, 80.0%).
Fatigue
We constructed a simple three-level index of fatigue duration: fatigued for weeks or months (longer-term fatigue, 37%), fatigued for minutes, hours, or days (short-term fatigue, 27.4%), and no fatigue (35.6%).
Impact of cancer
Impact of cancer was measured with four scales measuring the impact on four separate domains of life: Caregiving/finances (a = 0.77), Exercise/diet (a = 0.63), Social/emotional (a = 0.75), and Religiosity (a = 0.80) [20] .
Fear of recurrence
For the current study we used a 5-item version of the Fear of Recurrence scale [21] . Confirmatory CFI = 0.99, Tucker-Lewi factor analysis indicated that all items loaded onto one common factor (Comparative Fit Index s Index TLI = 0.99). The single factor accounted for 66% of the scale variance. Cronbach's a in the present sample was 0.82.
Analysis plan
The analyses presented in this paper use data collected through November 18th, 2004. The data were analyzed using SAS/STAT software, version 9 of the SAS System for Windows. Copyright Ó2002 SAS Institute Inc and version 3.01 of MPlus, which is a specialized software that is designed for analyzing ordinal level data [22] . SF-36 subscales with missing item responses were imputed following standard scoring methods [23] . Missing hormone-related symptoms and BCIA scale scores were imputed (for less than 3% of participants) based on the average of non-missing item responses, when at least 50% of the scale items were not missing; no imputation was necessary for the FOR scale responses. Imputation of missing values was not considered for any other measure. See Alfano et al. [19] for a figure of the enrollment process. For the analyses that are presented here, 1 woman did not have complete data sufficient to compute psychosocial scales; thus, the final sample size available for analysis was 804 women.
We fit linear regression models to evaluate the associations between race/ethnicity and socioeconomic variables with the study's QOL measures. Indicator variables representing the three HEAL sites were not included in our models due to their strong associations with the racial/ethnic groups recruited by each site. In addition, we did not use 24-month household income (collected at the 24-month follow-up interview) as a socioeconomic predictor in the regression models due to the extent of missing data reported. We used these intermediate outcomes of symptom reporting, impact of cancer, and fear of recurrence, along with fatigue and lymphedema, to predict the overall physical and mental functioning variables. Table 1 presents demographic and medical characteristics of the 804 participants who provided data at the QOL measurement point, compared to the 304 participants who did not provide QOL data at the follow-up period. As shown in this table, there were key differences in the distributions between the two groups of women. Non-completers were significantly more likely to be younger or older (P < 0.01), of lower educational attainment (P < 0.01), and either Black or Hispanic (P < 0.01). Also, non-completers were slightly, but significantly, more likely to be diagnosed at a more advanced breast cancer stage (P < 0.01) and more likely to have received treatment (P < 0.01).
Results
Data on physical and MH functioning summary scores by socioeconomic level and by race/ethnicity are provided in Table 2 . Race/ethnicity was a significant correlate of physical (P = 0.01) and mental (P < 0.01) summary scores. Black women reported statistically significantly lower PF scores, compared with White and Hispanic women, but higher MH scores compared with White and Hispanic women. Employment status was also significantly associated with PF (P < 0.01).
Restricting the analyses to women aged 35-64, the age of the Black women, or conducting analyses without the ''other'' race category, did not alter the pattern of findings. Figure 1 presents data on the specific and independent eight subscale scores for the SF-36, compared to national norms [23] . As seen in this figure, HEAL participants reported lower scores on most of the subscale scores, but particularly the PF, RP, and RE scores. The largest differences were in PF and RP subscales, where the scores for these breast cancer survivors were approximately one standard deviation below population means. Tables 3 and 4 present the results of analyses to determine the relationships between demographic variables and both hormone-related symptoms and BCIA scale scores. Significant relationships between symptom level and sociodemographic variables were reported for Black women versus other women in cognitive/mood (P < 0.01), incontinence (P < 0.01), and weight/appearance (P < 0.01) symptoms. Table 4 contains the results of the BCIA on five scales, each representing a different dimension of life. Scores for the Exercise/Diet subscale differed significantly by educational levels (P < 0.01). Higher education level was associated with a more positive impact of breast cancer on exercise/diet subscale (P for trend < 0.01). White and Black women reported a greater negative impact of cancer on the caregiving/finances domain, compared to Hispanic women. Hispanic women reported significantly greater positive impact of cancer on religiosity compared with both Black and White women. Employment levels were significantly related to the Caregiving/finances (P < 0.01) and Social/emotional (P = 0.05) scores, with women who were unemployed (seeking a job or on leave) reporting a greater negative impact of cancer than employed women. FOR scores were greater among White and Hispanic women, compared to Black women. Table 5 contains the results of regression models using both socioeconomic indicators from Table 2 and  potential mechanisms from Table 3 (hormonal and other symptoms, impact of cancer, and fear of recurrence) as correlates of physical and MH functioning scores. In the final model, where demographic and psychosocial variables were included together, race was significantly related to PF, with Black participants and participants in the ''Other'' ethnic category reporting poorer functioning compared to the White referent group (P < 0.01, 0.05). Not working outside the home, being retired or disabled and being unemployed (on leave, looking for work) were associated with poorer PF compared to currently working (P < 0.01, < 0.01). More severe urinary incontinence symptoms and greater fear of recurrence were both associated with lower PF scores (P = 0.04, 0.04, respectively). A less negative impact of cancer on the caregiver/financial domain was associated with an increase in PF (P = 0.01). However, a less negative impact of cancer on the social/emotional domain was related to a decrease in PF (P = 0.03). More positive impact of cancer on exercise/diet was related to an increase in PF (P < 0.01). In addition, current lymphedema and both short-and long-term fatigue were related to poorer PF (P < 0.01 for all three variables), in both the unadjusted and the adjusted models.
In the fully adjusted model, race/ethnicity was related to the MH component score. Black women reported better MH than White women (P = 0.06), whereas Hispanic women reported poorer MH than White women (P = 0.05). The variables that were found to be significant in the unadjusted model were still significantly related to the MH component score in the adjusted model. More severe cognitive/mood symptoms and greater fear of recurrence were associated with poorer MH (both P < 0.01). Less negative impact of cancer on the social/emotional domain was related to better MH (P < 0.01). Shortand long-term fatigue were significantly related to poorer MH in both unadjusted and adjusted analyses (both P < 0.01 for long-term fatigue; P = 0.01 and <0.01 for short-term fatigue). Self-reports of current lymphedema were positively and significantly related to MH summary score in the unadjusted analysis (P <0.01), but were only borderline significantly related to MH summary scores in the adjusted analyses (P = 0.06).
Discussion
These data suggest that women who are surviving breast cancer for over two years are doing relatively well. The values for the eight scales of the SF-36 were somewhat lower than population norms, but not in all areas [24] . The clinical significance of this magnitude of decrease is debatable and is likely to represent meaningful problems for some women and insignificant changes for others, depending on resilience and other complicating factors in a given woman's life. In general, however, these results show that women without recurrent or second primary cancers are generally able to recover from the diagnosis and treatment experience and continue with their lives. These findings are supported by recent studies on long-term survivor functioning [1] [2] [3] 5] . In adjusted models, we see that the most consistent correlates of long-term MH and PF are fear of recurrence, the impact of cancer on social and emotional life, and fatigue; all symptoms that continue to be reported in long-term survivor groups.
The demographic associations identify demographic subgroups of women who report poorer physical and mental functioning. One possible explanation for the poorer PF in Black women might be that Black women are diagnosed at later stages, and later stage of diagnosis is related to different, more invasive treatment options and possibly more morbidity. In our data, Black women were more likely to be diagnosed at a later stage (data not shown) and were more likely to have lymphedema symptoms that would likely decrease their PF (data not shown). However, we controlled for disease stage and included lymphedema in the adjusted models. There could be an additional factor such as increased spirituality, social support, or better post-traumatic growth that may account for both fewer symptoms and higher MH scores in Black women.
It is interesting that current lymphedema was related to higher levels of MH summary scores. The literature (e.g., [1] ) has shown the inverse relationship: persistent lymphedema is related to poorer MH outcomes. We conducted a post-hoc analysis to identify possible explanations for this unusual relationship. Black women had higher MH summary scores, as shown previously in Table 2 . In our posthoc analyses, Black women accounted for almost half (46.7%) of the participants reporting current lymphedema. Because of the higher frequency of Black women in the current lymphedema group, combined with higher reported MH summary scores, the mean for the entire group may have been increased. However, the adjusted models should have taken this into account.
This study has several strengths. One is to include women from a multiethnic sample with a broad range of socioeconomic levels. Many survivorship studies have focused on small samples consisting primarily of White women. In these data we were able to compare women from different ethnic groups and women at differing levels of education and employment. Documenting demographic differences is important as we move from clinical to population-based approaches when studying cancer patients into survivorship. Another strength of this study is the use of previously developed and widely used measures, allowing for comparisons to other studies. This study has several features that may limit the generalizability of the data. A higher proportion of women who completed the QOL follow-up assessments were White, more educated, and diagnosed at an earlier stage. However, participation was still relatively high due to the intensive follow-up procedures, and therefore we have confidence that the data from the follow-up do not show strong bias in this regard. Ethnic comparisons are not based on women equally recruited across sites, and therefore we cannot completely rule out the idea that race differences are due to center differences as much as differences among race or ethnic groups. Multiethnic samples recruited in the same ways from the same sites will address this question. Constant loss to the multiple procedures and follow-up efforts in this study resulted in a sample that is not fully generalizable to any population of cancer survivors. While this is somewhat less of a problem in the present sample, compared with other samples, one should keep this in mind when interpreting the data patterns. Finally, the study had measurement constraints of follow-up timing and survey length that resulted from the need for coordination across three distant sites. Overall, these data indicate that race/ethnicity and socioeconomic factors are important determinants of QOL in long term survivors. The final regression models explained a large amount of variance in QOL, 38 and 41% of the variance in physical and mental scores, respectively. Racial/ethnic and socioeconomic variables remained significant in these models after adjustment. These data suggest that race/ethnicity and socioeconomic status represent health disparities that are important for breast cancer survivors. Given the relative importance of these demographic variables on functioning, future studies should address interventions to reduce negative functioning in these groups.
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